秀丽隐杆线虫模型在记忆和遗忘行为研究中的运用

记忆是学习和掌握新知识的基础,遗忘则有助于保持大脑记忆系统的高效性,因此记忆与遗忘是大脑神经网络正常运作的重要组成部分。秀丽隐杆线虫生物体积小、生命周期短、易于识别单个神经元,已成为神经科学和行为学领域研究的理想模型之一,基于秀丽隐杆线虫模型的研究结合高等模式生物探索记忆和遗忘的机制将有助于揭示记忆和遗忘异常相关疾病的发生。综述了秀丽隐杆线虫广泛用于挥发性物质与病原菌的记忆与遗忘行为的分子机制研究,以及转基因线虫在记忆与遗忘相关疾病中的应用,旨在为后续记忆和遗忘的研究提供理论参考。     

青春期小鼠与成年小鼠在吗啡和食物诱导条件化位置偏爱建立上的异同

该实验通过采用吗啡诱导的条件位置偏爱(conditioned place preference,CPP)与食物诱导CPP相结合的方法来研究青春期小鼠和成年小鼠的普通学习记忆和成瘾学习记忆之间是否存在差异。结果发现:1)成年小鼠能够建立吗啡诱导CPP,而青春期小鼠不能建立;2)青春期小鼠和成年小鼠都能够建立食物诱导CPP。吗啡诱导CPP的结果提示,青春期小鼠和成年小鼠在成瘾学习记忆上有差异,青春期小鼠的成瘾记忆能力较弱。食物诱导CPP的结果提示,青春期小鼠和成年小鼠在普通学习记忆上没有差异。吗啡诱导CPP和食物诱导CPP的结果比较提示,小鼠的普通学习记忆系统和成瘾学习记忆系统发育进程是不平行的。     

学习与记忆神经机制研究进展

学习与记忆是大脑的重要高级功能,认知神经科学的迅速发展为探索学习与记忆的神经机制提供了新的思路和方法。突触的可塑性变化可能是记忆形成与巩固的分子与细胞机制,随着神经联结的形成,大脑构建出不同的记忆通路,不同类型的记忆又享有各自的记忆系统。对记忆的脑机制研究能够指导人们如何有效地提高记忆。论述了记忆的形成与巩固的神经机制,脑的记忆系统以及如何有效地提高记忆成绩。     

绞股蓝对电休克大鼠记忆障碍的改善作用

绞股蓝又名七叶胆,为葫芦科绞股蓝属植物。它具有多种药理活性,并有实验证明其具有增强学习记忆的功能。本实验主要验证绞股蓝对电休克法造成的SD大鼠记忆障碍的改善作用。实验方法分为四个过程:①建立大鼠的空间分辨学习记忆;②采用电休克的方法破坏大鼠的记忆,建立记忆遗忘的大鼠模型;③把记忆遗忘的大鼠模型随机分成两组,分别用2.5%绞股蓝提取物的溶液和0.9%生理盐水(每天每只8ml/100g)对两组模型大鼠进行灌胃饲养8天;④观察测试大鼠的空间分辨学习记忆的改善情况,用Y型迷宫模型测试出记忆错误次数、正确率、测试总时间和主动回避次数等参考指标。结果表明绞股蓝组与对照组相比,错误次数较少,正确率较高,测试总时间较短,主动回避次数较多。由此证明绞股蓝对SD大鼠记忆障碍有明显的改善作用。     

令人烦恼的记忆

记载着挫折、恐惧、绝望等负性情绪的负性记忆,具有难以遗忘、令人烦恼的特点,与一些脑重大疾病,如创伤后应激综合征、抑郁症等存在密切关系。研究表明NMDA受体依赖性长时程增强在记忆的获取、储存等过程中起着关键作用。电休克和NMDA受体拮抗剂氯胺酮已知可导致短暂性遗忘,应用于治疗创伤后应激综合征、抑郁症具有起效快、疗效好的显著特点,提示这类脑疾病可能与负性记忆的遗忘特点有关。最近报道,遗忘具有独立的分子机理,在记忆和遗忘机理的共同作用下,既可能发生"记不住"如老年痴呆症、也可能出现"忘不了"如创伤后应激综合征和抑郁症等。深入研究遗忘的细胞分子机理,无疑有助于我们认识、预防和治疗相关脑重大疾病。     

连接视觉长时记忆与视觉工作记忆的认知及其神经机制

视觉记忆系统主要由视觉长时记忆与视觉工作记忆组成,是人类信息存储的重要方式。自从Baddeley提出工作记忆的多成分模型以来,视觉工作记忆独立于长时记忆系统的观点一直占据着主导地位。然而,新的理论证据则支持两者之间具有紧密联系。基于所存储的信息具有不同表征状态的三嵌套成分模型,就把长时记忆与工作记忆纳入到一个统一的记忆系统中。一方面,视觉长时记忆能够利用其持久存储的性质来支持工作记忆的运作;另一方面,来自神经影像的证据也表明两者涉及共同的神经机制,并且整个视觉记忆系统呈现出从初级感觉皮层向前额叶皮层逐步递进的加工方式。同时,本文也为二者关系的未来研究提供展望。     

人参皂甙Rg1可改善吗啡依赖大鼠空间学习障碍

长时间应用阿片类制剂如吗啡、海洛因等会诱发脑的适应性改变,从而出现药物成瘾或依赖。以往研究显示,阿片成瘾在许多方面与学习记忆过程类似,相关学者认为是学习的一种异化形式,而这一异化行为的形成是脑内某一记忆系统非适应性回归介导的。另一方面,长时间应用阿片本身也会导致学习记忆能力受损。     

AGRIN在老年鼠大脑皮质和海马的表达

目的观察蛋白聚糖-agrin在大鼠大脑皮质和海马的表达,探讨agrin与记忆的关系.方法用抗agrin的多克隆抗体,免疫组化方法检测成年大鼠、记忆正常老年鼠以及记忆障碍的老年鼠大脑皮质和海马中agrin的表达变化.结果 Agrin在不同动物组的表达变化明显,在成年鼠和记忆正常的老年鼠的大脑皮质和海马agrin有较弱表达,但在记忆障碍的老年鼠其表达增加明显.结论 Agrin表达可能和大鼠的记忆障碍有关.     

老年稳定期精神分裂症患者睡眠障碍现状调查及对记忆功能的影响

摘要 目的：调查老年稳定期精神分裂症患者睡眠障碍现状,分析其影响因素,并分析老年稳定期精神分裂症患者睡眠障碍与记忆功能的关系。方法：选择2018年5月~2021年5月期间我院收治的100例老年稳定期精神分裂症患者。采用自制临床资料调查问卷采集患者临床资料,采用匹茨堡睡眠质量指数（PSQI）评价所有患者的睡眠状况,采用多维记忆评估量表（MMAS）评价所有患者的记忆功能,单因素及多因素Logistic回归分析老年稳定期精神分裂症患者睡眠障碍的影响因素。Pearson检验分析PSQI评分与记忆功能评分的相关性。结果：纳入的100例老年稳定期精神分裂症患者中,有68例发生睡眠障碍,睡眠障碍发生率为68.00%。根据患者有无睡眠障碍分为两组：睡眠障碍组（n=68）和无睡眠障碍组（n=32）。单因素分析结果显示：老年稳定期精神分裂症患者睡眠障碍与年龄、性别、户籍所在地、文化水平、婚姻状况、发病情况、收入情况有关（P<0.05）,而与精神症状无关（P>0.05）。多因素Logistic回归分析显示婚姻状况为未婚/离异/丧偶、户籍所在地为城镇、性别男、年龄>70岁、文化水平为中学、收入情况为无是老年稳定期精神分裂症患者睡眠障碍的危险因素（P＜0.05）。睡眠障碍组汉词记忆、汉词配对、图画记忆评分低于无睡眠障碍组,PSQI评分高于无睡眠障碍组（P<0.05）。老年稳定期精神分裂症伴睡眠障碍患者PSQI评分与汉词配对、图画记忆、汉词记忆评分呈负相关（P＜0.05）。结论：老年稳定期精神分裂症患者存在较高的睡眠障碍发生率,且受到年龄、性别、户籍所在地等多种因素的影响。睡眠障碍可影响患者记忆功能状况,睡眠障碍越严重,记忆功能越差。     

香水莲花提取物对东莨菪碱诱导记忆障碍小鼠学习记忆能力的影响

探究香水莲花提取物(Nymphaea hybrid extract,NHE)对东莨菪碱诱导记忆障碍小鼠的学习记忆能力的影响。采用腹腔注射东莨菪碱建立记忆障碍模型,Morris水迷宫实验测定小鼠空间学习和记忆能力。水迷宫实验结束后,断头处死小鼠,进行生化指标的测定。结果表明,与模型组小鼠相比,NHE干预后,小鼠的逃避潜伏期明显缩短(P <0. 01),目标象限停留时间百分比和穿越平台次数增加(P <0. 05或P <0. 01),小鼠海马和皮质区的SOD和GSH-PX活力显著升高(P <0. 01或P <0. 05),MDA含量极显著降低(P <0. 01),ACh E活性显著降低(P <0. 01),ACh含量增加(P <0. 01或P <0. 05)。同时,免疫印迹结果表明,NHE能够改善东莨菪碱引起小鼠海马和皮质中ERK、CREB磷酸化水平和BDNF蛋白表达的减少。综上,香水莲花提取物可以提高东莨菪碱诱导的记忆障碍小鼠的学习记忆能力,具体机制涉及缓解大脑的氧化应激损伤,平衡胆碱能系统,激活ERK-CREB-BDNF信号通路。     

非侵入性脑刺激应用于创伤后应激障碍和物质滥用障碍的记忆干预

记忆是进行思维、想象等高级心理活动的基础，是累积经验、促进个体生存的重要功能。然而，创伤后应激障碍和物质滥用障碍具有某种非适应性记忆过强的特征，不利于个体生存。因此，以病理性改变的记忆为靶点，通过削弱或更新非适应性记忆，可以达到缓解症状甚至治愈的目的。记忆并非是对经验的刻板记录，而是对经验不断更新整合的过程，因此记忆有被干预的可能。记忆的再次激活可能会诱发记忆消退和再巩固，这为记忆相关精神疾病的干预提供了思路和启发。非侵入性脑刺激（noninvasive brain stimulation,NIBS）技术作为一种时间、空间分辨率较高的无创神经调控技术，近年来开始被结合运用到记忆干预研究中。不同刺激参数的NIBS （如频率、极性，以及受刺激区域的初始神经激活状态）应用于特定大脑皮质区域，可以调节神经可塑性，增强或降低靶点脑区的兴奋性，从而削弱或增强行为表现，实现记忆消退增强或在再巩固时间窗内干预记忆。本文首先介绍了记忆相关的脑功能基础研究与局部脑区干预方案的理论联系，继而回顾了近年来NIBS与记忆干预相结合应用于创伤或物质滥用相关障碍的临床干预研究，为精神疾病临床诊疗提供理论依据和启发。     

Dopamine,sleep, and neuronal excitability modulate amyloid-β–mediated forgetting in Drosophila

Alzheimer disease (AD) is one of the main causes of age-related dementia and neurodegeneration. However, the onset of the disease and the mechanisms causing cognitive defects are not well understood. Aggregation of amyloidogenic peptides is a pathological hallmark of AD and is assumed to be a central component of the molecular disease pathways. Pan-neuronal expression of Aβ₄₂^Arctic peptides in Drosophila melanogaster results in learning and memory defects. Surprisingly, targeted expression to the mushroom bodies, a center for olfactory memories in the fly brain, does not interfere with learning but accelerates forgetting. We show here that reducing neuronal excitability either by feeding Levetiracetam or silencing of neurons in the involved circuitry ameliorates the phenotype. Furthermore, inhibition of the Rac-regulated forgetting pathway could rescue the Aβ₄₂^Arctic-mediated accelerated forgetting phenotype. Similar effects are achieved by increasing sleep, a critical regulator of neuronal homeostasis. Our results provide a functional framework connecting forgetting signaling and sleep, which are critical for regulating neuronal excitability and homeostasis and are therefore a promising mechanism to modulate forgetting caused by toxic Aβ peptides.

One of the early hallmarks in Alzheimer’s disease is increased forgetting. This study shows that restricted expression of amyloid beta in the memory center of fruit flies causes enhanced forgetting without affecting the ability to learn; forgetting is caused by increased excitability and can be restored with drugs, increased sleep or modulation of dopamine signalling.     

Inhibition of Rac1-dependent forgetting alleviates memory deficits in animal models of Alzheimer’s disease

Accelerated forgetting has been identified as a feature of Alzheimer’s disease (AD), but the therapeutic efficacy of the manipulation of biological mechanisms of forgetting has not been assessed in AD animal models. Ras-related C3 botulinum toxin substrate 1 (Rac1), a small GTPase, has been shown to regulate active forgetting in Drosophila and mice. Here, we showed that Rac1 activity is aberrantly elevated in the hippocampal tissues of AD patients and AD animal models. Moreover, amyloid-beta 42 could induce Rac1 activation in cultured cells. The elevation of Rac1 activity not only accelerated 6-hour spatial memory decay in 3-month-old APP/PS1 mice, but also significantly contributed to severe memory loss in aged APP/PS1 mice. A similar age-dependent Rac1 activity-based memory loss was also observed in an AD fly model. Moreover, inhibition of Rac1 activity could ameliorate cognitive defects and synaptic plasticity in AD animal models. Finally, two novel compounds, identified through behavioral screening of a randomly selected pool of brain permeable small molecules for their positive effect in rescuing memory loss in both fly and mouse models, were found to be capable of inhibiting Rac1 activity. Thus, multiple lines of evidence corroborate in supporting the idea that inhibition of Rac1 activity is effective for treating AD-related memory loss.     

The Endocannabinoid System and Extinction Learning

The endocannabinoid system has emerged as a versatile neuromodulatory system, implicated in a plethora of physiological and pathophysiological processes. Cannabinoid receptor type 1 (CB1 receptor) and endocannabinoids are widely distributed in the brain. Their roles in learning and memory have been well documented, using rodents in various memory tests. Depending on the test, the endocannabinoid system is required in the acquisition and/or extinction of memory. In particular, the activation of CB1 receptor-mediated signaling is centrally involved in the facilitation of behavioral adaptation after the acquisition of aversive memories. As several human psychiatric disorders, such as phobia, generalized anxiety disorders, and posttraumatic stress disorder (PTSD) appear to involve aberrant memory processing and impaired adaptation to changed environmental conditions, the hope has been fuelled that the endocannabinoid system might be a valuable therapeutic target for the treatment of these disorders. This review summarizes the current data on the role of the endocannabinoid system in the modulation of extinction learning.     

Forgetting : theories and potential mechanisms

The cellular and molecular mechanisms of learning and memory are extremely complex and not well understood. The mechanisms of forgetting are even further more unclear, but several theories have been formulated to explain their cause and origin. Forgetting has recently been revealed to recruit specific mechanisms and anatomical basis which some components are distinct from those of learning and memory. Forgetting appears to depend essentially on protein phosphatases, enzymes highly abundant in the brain that are able to regulate numerous biochemical targets in neurons. The formation of memory by contrast depends on protein kinases. Memory and forgetting are indeed reciprocally controlled by a balance between kinases et phosphatases that determines the efficacy of learning and the persistence of memory. This review provides a brief account of the main features of forgetting and a summary of the most recent findings on its potential mechanisms.     

Stress-induced out-of-context activation of memory

Inappropriate recollections and responses in stressful conditions are hallmarks of post-traumatic stress disorder and other anxiety and mood disorders, but how stress contributes to the disorders is unclear. Here we show that stress itself reactivates memories even if the memory is unrelated to the stressful experience. Forced-swim stress one day after learning enhanced memory recall. One-day post-learning amnestic treatments were ineffective unless administered soon after the swim, indicating that a stressful experience itself can reactivate unrelated consolidated memories. The swim also triggered inter-hemispheric transfer of a lateralized memory, confirming stress reactivates stable memories. These novel effects of stress on memory required the hippocampus although the memories themselves did not, indicating hippocampus-dependent modulation of extra-hippocampal memories. These findings that a stressful experience itself can activate memory suggest the novel hypothesis that traumatic stress reactivates pre-trauma memories, linking them to memory for the trauma and pathological facilitation of post-traumatic recall.     

Memory and anxiety disorders.

Experimental psychopathologists have identified varying patterns in memory bias in people with depressive and anxiety disorders. Individuals suffering from depression tend to exhibit explicit memory deficits for positively-valanced material, and sometimes exhibit biases for retrieving negative self-relevant information as well. Most studies, however, provide scant evidence for implicit memory biases in depression. In contrast to depression, anxiety disorders are rarely associated with enhanced explicit memory for threat-related information (with the exception of panic disorder). Evidence for implicit memory biases for threat in these syndromes is mixed. After providing an overview of findings on memory abnormalities in depressive and anxiety disorders, data from several new studies bearing on posttraumatic stress disorder (PTSD) in Vietnam combat veterans and in women with histories of childhood sexual abuse are presented. Involving directed forgetting, implicit memory and autobiographical cueing paradigms, these experiments point to a pattern of abnormalities linked to PTSD rather than to trauma per se.     

Tau蛋白在阿尔茨海默病中的作用

阿尔茨海默病(AD)是非常普遍的神经变性性疾病并且是老年人痴呆的主要原因。AD患者的症状特点包括进行性的认知障碍、记忆丧失和行为障碍,与大脑中的病理变化密切相关。AD现成为全球最严重的健康和社会经济问题。在AD患者脑中神经纤维网或神经营养障碍的过程中存在tau蛋白的异常。tau蛋白丧失其促微管组装的生物学功能,导致细胞骨架的破坏、丝状物形成和神经缠结,轴突运输损害,进而导致突触蛋白失去功能和神经退行性病变。其数量和结构的改变将会影响其功能而且会出现异常聚集。调节Tau蛋白的异常聚集的分子机制主要是一些翻译后修饰使其结构及构象发生变化。因此,异常磷酸化和截断的tau蛋白作为tau蛋白病理过程的关键机制而引起学者关注。本文描述了tau蛋白的结构和功能及其在AD中的主要病理变化,同时在本文中还涉及到磷酸化的tau蛋白是神经元对氧化应激的代偿反应这一观点。对tau蛋白进行更加全面的解读。     

Xenon Impairs Reconsolidation of Fear Memories in a Rat Model of Post-Traumatic Stress Disorder (PTSD)

Xenon (Xe) is a noble gas that has been developed for use in people as an inhalational anesthestic and a diagnostic imaging agent. Xe inhibits glutamatergic N-methyl-D-aspartate (NMDA) receptors involved in learning and memory and can affect synaptic plasticity in the amygdala and hippocampus, two brain areas known to play a role in fear conditioning models of post-traumatic stress disorder (PTSD). Because glutamate receptors also have been shown to play a role in fear memory reconsolidation – a state in which recalled memories become susceptible to modification – we examined whether Xe administered after fear memory reactivation could affect subsequent expression of fear-like behavior (freezing) in rats. Male Sprague-Dawley rats were trained for contextual and cued fear conditioning and the effects of inhaled Xe (25%, 1 hr) on fear memory reconsolidation were tested using conditioned freezing measured days or weeks after reactivation/Xe administration. Xe administration immediately after fear memory reactivation significantly reduced conditioned freezing when tested 48 h, 96 h or 18 d after reactivation/Xe administration. Xe did not affect freezing when treatment was delayed until 2 h after reactivation or when administered in the absence of fear memory reactivation. These data suggest that Xe substantially and persistently inhibits memory reconsolidation in a reactivation and time-dependent manner, that it could be used as a new research tool to characterize reconsolidation and other memory processes, and that it could be developed to treat people with PTSD and other disorders related to emotional memory.